El tratamento del cancro ai polmoni dipende da diversi fatori, tra cui el stadio del cancro, el tipo de cancro ai polmoni e a salute del pasiente.
Serte opsion de tratamento comuni łe include:
1. Chirurgia: Speso xe el tratamento preferìo pa'l cancro ai polmoni in fase iniziałe.
El chirurgo cava el tumore e na picia parte de tessudo sano intorno.
2. Radioterapia: Ła radiasion a alta energia ła vien doparada pa copar łe sèłułe del cancro e far ridur i tumori.
El pol esar usà da soło o in conbinasion co altri tratamenti.
3. Chimioterapia:'sto tratamento usa droghe pa copar e cellule del cancro.
Se pol darlo par via intravenosa o oralmente, e spesso se usa in combinassiòn co altri tratamenti.
4. Terapia mirà:'sto tratamento mira a geni o proteine specifici che contribuise ała cressita e ała sopravivensa dełe cellule cancerose.
El vien spesso usà pa'l cancro al polmone avanzà o metastatico.
5. Immunoterapia:'sto tratamento aiuta el sistema immunitario a riconosser e atacar e cellule cancerose.
El vien spesso usà pa'l cancro al polmone avanzà o metastatico.
6. Terapia fotodinamica:'sto tratamento usa un farmaco ativà dała luce pa copar e cellule cancerose.
El vien spesso usà pa'l cancro ai polmoni in fase iniziale.
7. Terapia dei protoni: xe un tipo de terapia de radiasion che usa i protoni al posto dei raggi X pa darghe radiasion al tumore.
El vien spesso usà pa'l cancro ai polmoni in fase iniziale.
8. Prove cliniche: I pasienti i pol esar elegìbiłi a partesipar a prove cliniche che prova novi tratamenti o combinassiòn de tratamenti.
Xe importante discutar dełe mejo opsion de tratamento co un grupo de cura, parché el piano de tratamento pì efetivo dipenderà dała situasion specifica de l'individuo.
Chen JH, Wu J, Xu Q: The emerging treatment landscape of targeted therapy in non-small-cell lung cancer. Signal Transduct Target Ther. , 4 (): 61.
Furuse K: [Photodynamic therapy of centrally located early-stage lung cancer]. Gan To Kagaku Ryoho. 1996, 23 (1): 27-30.
Gálffy G: [From rare mutations to classical ones, inhibition of signaling pathways in non-small cell lung cancer]. Magy Onkol. 2020, 64 (3): 196-204.
Magalhães M, Alvarez-Lorenzo C, Concheiro A, Figueiras A, Santos AC, Veiga F: RNAi-based therapeutics for lung cancer: biomarkers, microRNAs, and nanocarriers. Expert Opin Drug Deliv. 2018, 15 (10): 965-982.
Kataoka M, Fujiwara T, Tanaka N: [Gene therapy for lung cancer]. Nihon Geka Gakkai Zasshi. 2002, 103 (2): 244-9.
Jin C, Yang B: A Case of Delayed Diagnostic Pulmonary Tuberculosis during Targeted Therapy in an EGFR Mutant Non-Small Cell Lung Cancer Patient. Case Rep Oncol. , 14 (1): 659-663.
Wang Y, Liu Q, Chen H, You J, Peng B, Cao F, Zhang X, Chen Q, Uzan G, Xu L, Zhang D: Celastrol improves the therapeutic efficacy of EGFR-TKIs for non-small-cell lung cancer by overcoming EGFR T790M drug resistance. Anticancer Drugs. 2018, 29 (8): 748-755.
['Disclaimer: medego']
['Sto sito web el xe fornìo solo par scopi educativi e informativi e no el costituise un consejo mèdego o servisi profesionali.']
['Łe informasion fornìe no łe ga da esar usà pa diagnosticar o curar un problema de salute o na malatia, e chi che serca un consijo mèdego personal el ga da consultar un mèdego licensià.']
['Te prego de notare che a rete neurałe che ła genera risposte ałe domande, ła xe particołarmente imprecisa quando se trata de contenuti numèrici, par exenpio el nùmaro de persone a cui xe stà diagnosticà na determinada małatia.']
['Serca senpre el consijo del to dotor o de un altro fornitor de sałute cualificà riguardo a na condision mèdega. Mai trascurar el consijo mèdego profesionałe o ritardarlo nel sercarlo par via de calcossa che te ghè leto su sto sito. Se te pensi de aver na emergensa mèdega, ciama el 911 o va al pronto socorso pì visin imediatamente.']
['Disclaimer: copyright']
['El Digital Millennium Copyright Act del 1998, 17 U.S.C. § 512 (el DMCA) el dà ricorso ai proprietari de copyright che i crede che el material che vien fora su Internet infranga i so diriti soto ła lege sui copyright dei Stati Uniti. ']
["Se te credi in bona fede che un contenuto o un material messo a dispoxision in conesion col nostro sito o i nostri servisi infranga i to diriti de autor, ti (o el to agente) te pol mandarne na notisia domandando che el contenuto o el material sia rimoso, o che l'acesso sia blocà."]
['I avixi i ga da esare mandà par scrito via e-mail (varda ła sezion "Contato" pa\'l indiriso e-mail).']
["El DMCA richiede che a to notisia de presunta violasion de copyright includa e seguenti informasion: (1) descrixion del lavoro proteto da copyright che xe l'ogeto de ła presunta violasion; (2) descrixion del presunto contenuto che viola e informasion sufisente par permeterne a noi de localixar el contenuto; (3) informasion de contato, incluxo el to indirizo, numero de telefono e indirizo email; (4) na dichiarasion da parte tua che te credi in bona fede che el contenuto nel modo reclamà no xe autorizà dal proprietario del copyright, o dal so agente, o da l'operasion de nisuna lege; "]
["(5) 'na to dichiarasion, firmada soto pena de spergiuro, che łe informasion neła notìfega xe precise e che te ghè l'autorità de far valer i diriti de autor che i xe stai violadi;"]
['e (6) na firma fisica o ełetrònica del titołare del copyright o de na persona autorizada a agire a nome del titołare del copyright. ']
['Se no te meti tute łe informasion sora łe pol far in modo che el tratamento del to reclamo el se intardi.']
['Contato']
['Ve prego de mandarne na mail co qualsiasi domanda/suggerimento.']
How to treat lung cancer?
The treatment for lung cancer depends on several factors, including the stage of the cancer, the type of lung cancer, and the patient's overall health.
Some common treatment options include:
1. Surgery: This is often the preferred treatment for early-stage lung cancer.
The surgeon removes the tumor and a small portion of healthy tissue around it.
2. Radiation therapy: High-energy radiation is used to kill cancer cells and shrink tumors.
It can be used alone or in combination with other treatments.
3. Chemotherapy: This treatment uses drugs to kill cancer cells.
It can be given intravenously or or orally, and is often used in combination with other treatments.
4. Targeted therapy: This treatment targets specific genes or proteins that contribute to the growth and survival of cancer cells.
It is often used for advanced or metastatic lung cancer.
5. Immunotherapy: This treatment helps the immune system recognize and attack cancer cells.
It is often used for advanced or metastatic lung cancer.
6. Photodynamic therapy: This treatment uses a light-activated drug to kill cancer cells.
It is often used for early-stage lung cancer.
7. Proton therapy: This is a type of radiation therapy that uses protons instead of x-rays to deliver radiation to the tumor.
It is often used for early-stage lung cancer.
8. Clinical trials: Patients may be eligible to participate in clinical trials testing new treatments or combinations of treatments.
It is important to discuss the best treatment options with a healthcare team, as the most effective treatment plan will depend on the individual's specific situation.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['Circa']
['BioMedLib usa computer automatici (algoritmi de machine-learning) pa generar coppie de domande e risposte.']
['Cominsiemo co 35 milioni de publicassioni biomediche de PubMed/Medline. e anca pagine web de RefinedWeb.']
